This page shows the latest chronic lung disease news and features for those working in and with pharma, biotech and healthcare.
This includes influenza patients who have conditions including asthma, chronic lung disease, diabetes, heart disease or morbid obesity or adults aged 65 and over.
On Wednesday, the European Commission granted Moderna’s COVID-19 vaccine, initially called mRNA-1273, a conditional marketing authorisation to prevent the disease in people aged 18 years and older. ... The trial also showed a 90.9% efficacy rate in
The trial also showed a 90.9% efficacy rate in participants who were at risk of developing severe COVID-19 infection, including people with chronic lung disease, heart disease, obesity, liver ... disease, diabetes or HIV infection.
The trial also showed a 90.9% efficacy rate in participants who were at risk of developing severe COVID-19 infection, including people with chronic lung disease, heart disease, obesity, liver ... disease, diabetes or HIV infection.
This includes influenza patients who have conditions including asthma, chronic lung disease, diabetes, heart disease or morbid obesity or adults aged 65 and over.
It can now add that it is the first and only antiviral medicine indicated for high-risk patients, such as those who have conditions including asthma, chronic lung disease, diabetes, heart ... Levi Garraway. “People with chronic conditions such as asthma
More from news
Approximately 1 fully matching, plus 20 partially matching documents found.
People with chronic conditions such as diabetes, lung disease, and heart disease, and those of advanced age, had a poorer prognosis once infected with COVID-19. ... In the U.S., fewer healthcare providers have training, knowledge, and expertise in
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...